Cart
sales@molnova.com
Propafenone HCl
CAS No. 34183-22-7
Propafenone HCl( Propafenone Hydrochloride | Propafenone HCl )
Catalog No. M18442 CAS No. 34183-22-7
Propafenone HCl is a classic anti-arrhythmic medication, which treats illnesses associated with rapid heartbeats such as atrial and ventricular arrhythmias.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | 27 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePropafenone HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionPropafenone HCl is a classic anti-arrhythmic medication, which treats illnesses associated with rapid heartbeats such as atrial and ventricular arrhythmias.
-
DescriptionPropafenone Hydrochloride is a sodium channel protein inhibitor. Propafenone Hydrochloride is an inhibitor of AR.
-
In Vitro——
-
In Vivo——
-
SynonymsPropafenone Hydrochloride | Propafenone HCl
-
PathwayOthers
-
TargetOther Targets
-
RecptorSodium Channel
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number34183-22-7
-
Formula Weight377.9
-
Molecular FormulaC21H27NO3·HCl
-
Purity>98% (HPLC)
-
SolubilityDMSO : 33.33 mg/mL 88.20 mM; H2O : 0.67 mg/mL 1.77 mM;
-
SMILESCCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1
-
Chemical Name1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one;hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Mauritianin
Mauritianin is a kaempferol glycoside isolated from the flowers and leaves of Acalypha indica and is a topoisomerase I inhibitor.Mauritianin has cytoprotective activity.
-
PROPYL DISULFIDE
PROPYL DISULFIDE is a natural product.
-
BMS986260
BMS-986260 is a selective, and orally bioavailable TGFβR1 inhibitor(IC50 = 1.6 nM). BMS-986260?demonstrated functional activity in multiple TGFβ-dependent cellular assays, excellent kinome selectivity, favorable pharmacokinetic properties, and curative in vivo efficacy in combination with anti-PD-1 antibody in murine colorectal cancer (CRC) models.?
